We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+11.18%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$3.07B
AUM Growth
+$226M
Cap. Flow
-$6.05M
Cap. Flow %
-0.2%
Top 10 Hldgs %
24.71%
Holding
329
New
29
Increased
101
Reduced
173
Closed
14

Sector Composition

Rank Sector Weight
1 Healthcare 25.97%
2 Technology 23.54%
3 Industrials 17.51%
4 Consumer Discretionary 11.34%
5 Communication Services 7.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRKR icon
151
Bruker
BRKR
$8.14B
$2.88M 0.09%
44,870
-1,811
-4% -$109K
ATRS
152
DELISTED
Antares Pharma, Inc.
ATRS
$2.88M 0.09%
701,499
+101,871
+17% +$441K
PFPT
153
DELISTED
Proofpoint, Inc.
PFPT
$2.85M 0.09%
22,631
-1,016
-4% -$132K
ALNT icon
154
Allient
ALNT
$1.92B
$2.82M 0.09%
82,479
-657
-0.8% -$21.7K
NEO icon
155
NeoGenomics
NEO
$2.13B
$2.82M 0.09%
58,467
-351
-0.6% -$18.3K
TVTX icon
156
Travere Therapeutics
TVTX
$5.78B
$2.79M 0.09%
111,900
+36
+0% +$995
EW icon
157
Edwards Lifesciences
EW
$51.7B
$2.73M 0.09%
32,666
-2,323
-7% -$196K
CBZ icon
158
CBIZ
CBZ
$2.96B
$2.73M 0.09%
83,502
-105
-0.1% -$3.09K
IIN
159
DELISTED
IntriCon Corporation
IIN
$2.69M 0.09%
104,717
-624
-0.6% -$13.8K
ZBH icon
160
Zimmer Biomet
ZBH
$18.4B
$2.68M 0.09%
17,248
-853
-5% -$132K
CLAR icon
161
Clarus
CLAR
$143M
$2.68M 0.09%
156,990
-1,347
-0.9% -$22.9K
RMAX icon
162
RE/MAX Holdings
RMAX
$242M
$2.67M 0.09%
67,844
+13,604
+25% +$533K
XYL icon
163
Xylem
XYL
$28.1B
$2.66M 0.09%
25,299
-1,639
-6% -$166K
HUBG icon
164
HUB Group
HUBG
$2.92B
$2.62M 0.09%
+78,008
New +$2.34M
FMC icon
165
FMC
FMC
$1.33B
$2.61M 0.09%
23,626
-3,695
-14% -$409K
EXPO icon
166
Exponent
EXPO
$3.24B
$2.6M 0.08%
26,680
-69
-0.3% -$6.47K
PRVB
167
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$2.59M 0.08%
247,195
+79
+0% +$1.11K
TTC icon
168
Toro Company
TTC
$9.49B
$2.59M 0.08%
25,111
-4,602
-15% -$460K
ERII icon
169
Energy Recovery
ERII
$443M
$2.57M 0.08%
140,070
-57,129
-29% -$915K
MGNI icon
170
Magnite
MGNI
$3.55B
$2.56M 0.08%
61,475
-48,631
-44% -$2.11M
CSCO icon
171
Cisco
CSCO
$479B
$2.54M 0.08%
49,097
-750
-2% -$35.2K
ESTA icon
172
Establishment Labs
ESTA
$2.28B
$2.53M 0.08%
40,454
+12
+0% +$692
INGN icon
173
Inogen
INGN
$164M
$2.52M 0.08%
48,021
+185
+0.4% +$9.23K
TCMD icon
174
Tactile Systems Technology
TCMD
$665M
$2.5M 0.08%
45,786
+12,516
+38% +$671K
ONT
175
Onterris Inc
ONT
$580M
$2.49M 0.08%
49,642
-18,399
-27% -$777K

Similar funds

Rice Hall James & Associates's Q1 2021 Portfolio in Review

As of Q1 2021, Rice Hall James & Associates held 329 positions worth $3.07B, up 7.9% from $2.84B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Rice Hall James & Associates's Q1 2021 filing shows 29 new, 101 increased, 173 reduced and 14 closed positions. Its largest new stake was Biohaven Pharmaceutical Holding Company Ltd.: 264,558 shares worth $18.1M. The largest sale was Etsy, an estimated $49.1M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 26% a quarter earlier, followed by Technology and Industrials.

  • Rice Hall James & Associates's largest Q1 2021 buy was Biohaven Pharmaceutical Holding Company Ltd.: 264,558 shares worth $18.1M.
  • Rice Hall James & Associates added most to Stride in Q1 2021, an estimated $15.5M increase.
  • Rice Hall James & Associates's biggest Q1 2021 reduction was Etsy, cutting an estimated $49.1M.
  • Rice Hall James & Associates fully exited Grand Canyon Education in Q1 2021, selling an estimated $6.68M.
  • Rice Hall James & Associates's ten largest holdings make up 25% of its $3.07B portfolio in Q1 2021.
  • Rice Hall James & Associates opened 29 new positions and closed 14 in Q1 2021.
  • Rice Hall James & Associates's portfolio value rose 7.9% quarter-over-quarter to $3.07B.

Based on Rice Hall James & Associates's 13F filing for Q1 2021, filed 14 May 2021.